Acute myocardial infarction at 25 years of age.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1200674)

Published in Proc (Bayl Univ Med Cent) on July 01, 2004

Authors

M Wayne Falcone1, Paul A Grayburn, William C Roberts

Author Affiliations

1: Mid-Tex Cardiovascular Institute at Providence Health Center, Waco, Texas, USA.

Articles cited by this

Acute myocardial infarction in the young--The University of Michigan experience. Am Heart J (2002) 2.38

Long-term follow-up of coronary artery disease presenting in young adults. J Am Coll Cardiol (2003) 2.30

Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol (1995) 1.94

Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J (1995) 1.90

Myocardial infarction before age 36: risk factor and arteriographic analysis. Am J Cardiol (1982) 1.29

Myocardial infarction in young patients: an analysis by age subsets. Circulation (1986) 1.19

Long-term prognosis of patients having acute myocardial infarction when </=40 years of age. Am J Cardiol (2004) 1.13

Coronary artery disease in young women: risk factor analysis and long-term follow-up. Cleve Clin J Med (1993) 1.10

Myocardial infarction and other vascular diseases in young women. Role of estrogens and other factors. JAMA (1978) 1.02

Myocardial infarction in young adults under 30 years: risk factors and clinical course. Clin Cardiol (1987) 0.98

Long range observations in fifty-three young patients with myocardial infarction. Am J Cardiol (1967) 0.95

Myocardial infarction in young Indian patients: risk factors and coronary arteriographic profile. Am Heart J (1986) 0.91

Coronary anatomy and prognosis of young, asymptomatic survivors of myocardial infarction. Am J Med (1994) 0.91

Comparison of thrombolytic therapy for acute myocardial infarction in patients aged < 35 and > 55 years. Am J Cardiol (1993) 0.88

Prognosis of symptomatic coronary artery disease in young adults aged 40 years or less. Am J Cardiol (1987) 0.88

Long-term prognosis of young patients after myocardial infarction in the thrombolytic era. Clin Cardiol (1997) 0.87

Myocardial infarction in young adults: risk factors and natural history. Am Heart J (1983) 0.84

Acute myocardial infarction in a young South African Indian-based population: patient characteristics on admission and gender-specific risk factor prevalence. Curr Med Res Opin (2002) 0.82

[Myocardial infarct before the age of 36: 20 cases]. Arch Mal Coeur Vaiss (1978) 0.81

[Myocardial infarction before the age of 35. Clinical and coronarographic aspects]. Presse Med (1983) 0.78

Acute myocardial infarction in young and very old Chinese adults: clinical characteristics and therapeutic implications. Int J Cardiol (1994) 0.78

[Acute myocardial infarct in young adults. A report of 142 cases]. Arch Inst Cardiol Mex (1994) 0.78

Articles by these authors

Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr (2003) 11.88

Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr (2009) 3.00

The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol (2009) 2.91

The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol (2009) 2.20

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature. Clin Cancer Res (2007) 2.19

Thinking outside the "box"-the ultrasound contrast controversy. J Am Coll Cardiol (2007) 2.06

Thrombotic occlusion of the aortic ostia of saphenous venous grafts early after coronary artery bypass grafting by using the Symmetry aortic connector system. J Thorac Cardiovasc Surg (2002) 2.04

Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation (2003) 2.03

Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J Am Soc Echocardiogr (2002) 1.98

Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91

Echocardiographic indices do not reliably track changes in left-sided filling pressure in healthy subjects or patients with heart failure with preserved ejection fraction. Circ Cardiovasc Imaging (2011) 1.86

Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA (2009) 1.75

Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management. J Inherit Metab Dis (2011) 1.70

Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol (2005) 1.61

A suggested roadmap for cardiovascular ultrasound research for the future. J Am Soc Echocardiogr (2011) 1.60

Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci U S A (2006) 1.57

AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol (2008) 1.54

Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol (2003) 1.54

The editor's roundtable: psoriasis, inflammation, and coronary artery disease. Am J Cardiol (2008) 1.45

Established preoperative risk factors do not predict long-term survival in isolated coronary artery bypass grafting patients. Ann Thorac Surg (2012) 1.44

Etiologic considerations in the patient with syncope and an apparently normal heart. Arch Intern Med (2003) 1.43

Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation. Am J Cardiol (2013) 1.43

The editor's roundtable: atherosclerosis regression. Am J Cardiol (2008) 1.42

The editor's roundtable: JUPITER follow-up. Am J Cardiol (2011) 1.39

Diagnosis of congenital unicuspid aortic valve by 64-slice cardiac computed tomography. Proc (Bayl Univ Med Cent) (2008) 1.38

The editor's roundtable: pathophysiology and management of hyponatremia and the role of vasopressin antagonists. Am J Cardiol (2011) 1.38

Preoperative exclusion of significant coronary artery disease by 64-slice CT coronary angiography in a patient with a left atrial myxoma. Proc (Bayl Univ Med Cent) (2006) 1.34

Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol (2005) 1.23

DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol (2002) 1.22

Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol (2005) 1.19

Valvular heart disease: aortic regurgitation. Circulation (2005) 1.19

Cardiomyocyte-specific endothelin A receptor knockout mice have normal cardiac function and an unaltered hypertrophic response to angiotensin II and isoproterenol. Mol Cell Biol (2003) 1.15

Mitral "annular" calcium forming a complete circle "O" causing mitral stenosis in association with a stenotic congenitally bicuspid aortic valve and severe coronary artery disease. Am J Geriatr Cardiol (2006) 0.96

Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiography (2002) 0.96

Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST). Circulation (2003) 0.95

Transient overexpression of cyclin D2/CDK4/GLP1 genes induces proliferation and differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle (2012) 0.92

Effect on right ventricular volume of percutaneous Amplatzer closure of atrial septal defect in adults. Am J Cardiol (2005) 0.90

Non-invasive coronary angiography using multislice computed tomography. Heart (2005) 0.90

In vivo targeted delivery of ANGPTL8 gene for beta cell regeneration in rats. Diabetologia (2015) 0.89

Grading severity of mitral regurgitation by echocardiography: science or art? JACC Cardiovasc Imaging (2010) 0.88

Safety of ultrasound contrast agents in patients with known or suspected cardiac shunts. Am J Cardiol (2013) 0.88

Relation of obesity to atrial fibrillation after isolated coronary artery bypass grafting. Am J Cardiol (2008) 0.86

Preoperative visualization of a muscular ventricular septal defect by 64-slice cardiac computed tomography. Proc (Bayl Univ Med Cent) (2008) 0.85

Measurement of right ventricular volumes before and after atrial septal defect closure using multislice computed tomography. Am J Cardiol (2007) 0.85

Dramatic RV volume reduction following atrial septal defect closure demonstrated by multi-slice CT volume rendering. Clin Cardiol (2006) 0.85

Isolated ventricular septal defect caused by nonpenetrating trauma to the chest. Proc (Bayl Univ Med Cent) (2002) 0.85

Drug and gene delivery and enhancement of thrombolysis using ultrasound and microbubbles. Cardiol Clin (2004) 0.84

Advances in the assessment of no-reflow after successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: now that we can diagnose it, what do we do about it? J Am Coll Cardiol (2008) 0.84

Percutaneous mitral valve repair in the initial EVEREST cohort: evidence of reverse left ventricular remodeling. Circ Cardiovasc Imaging (2013) 0.83

Effect of body mass index on risk of long-term mortality following coronary artery bypass grafting. Am J Cardiol (2006) 0.83

Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation. Am J Cardiol (2004) 0.83

Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol (2013) 0.83

Islet purification method using large bottles effectively achieves high islet yield from pig pancreas. Cell Transplant (2012) 0.83

Comparing long-term survival between patients undergoing off-pump and on-pump coronary artery bypass graft operations. Ann Thorac Surg (2011) 0.83

Product safety compromises patient safety (an unjustified black box warning on ultrasound contrast agents by the Food and Drug Administration). Am J Cardiol (2008) 0.82

Color flow imaging of the vena contracta in mitral regurgitation: technical considerations. J Am Soc Echocardiogr (2003) 0.82

AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. Am J Cardiol (2010) 0.82

Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. Am J Cardiol (2007) 0.82

Ischemic and functional mitral regurgitation in heart failure: natural history and treatment. Curr Cardiol Rep (2014) 0.82

Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol (2004) 0.81

Ultrasound contrast agents: balancing safety versus efficacy. Expert Opin Drug Saf (2009) 0.81

The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk. Am J Cardiol (2005) 0.81

Syndrome of protein C deficiency and anterior wall acute myocardial infarction at a young age from a single coronary occlusion with otherwise normal coronary arteries. Am J Cardiol (2003) 0.81

The editor's roundtable: nonsteroidal antiinflammatory drugs and cardiovascular risk. Am J Cardiol (2008) 0.81

Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr (2010) 0.80

Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2006) 0.80

Heart transplantation for undiagnosed cardiac sarcoidosis. Am J Cardiol (2002) 0.80

Potential bioeffects of ultrasonic destruction of microbubble contrast agents. J Am Coll Cardiol (2006) 0.80

The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure. Am J Cardiol (2010) 0.80

Effect of Optison on pulmonary artery systolic pressure and pulmonary vascular resistance. Am J Cardiol (2013) 0.80

Isolated atrial amyloidosis and the importance of molecular classification. Proc (Bayl Univ Med Cent) (2013) 0.80

Community violence exposure and post-traumatic stress reactions among Gambian youth: the moderating role of positive school climate. Soc Psychiatry Psychiatr Epidemiol (2009) 0.80

Assessment of low-gradient aortic stenosis with dobutamine. Circulation (2006) 0.80

The editor's roundtable: the JUPITER trial--initial results and clinical implications. Am J Cardiol (2009) 0.79

The Editor's Roundtable: cardiac valve surgery. Am J Cardiol (2007) 0.79

Risk of death in heart disease is associated with elevated urinary globotriaosylceramide. J Am Heart Assoc (2014) 0.79

Safety of drug-eluting stents in the coronary artery in ST-elevation myocardial infarction at a single high-volume medical center. Am J Cardiol (2007) 0.79

Stress echo without the stress: detection of coronary stenosis at rest by myocardial contrast echocardiography. Circulation (2005) 0.79

The editor's roundtable: contrast-induced nephropathy. Am J Cardiol (2007) 0.79

Imaging of low-gradient severe aortic stenosis. JACC Cardiovasc Imaging (2013) 0.79

Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST). J Card Fail (2007) 0.79

A retrospective comparison of mortality in critically ill hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. JACC Cardiovasc Imaging (2010) 0.79

The Editor's Roundtable: Endothelial dysfunction in cardiovascular disease. Am J Cardiol (2008) 0.78

AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol (2010) 0.78

Improvement of porcine islet isolation by inhibition of trypsin activity during pancreas preservation and digestion using α1-antitrypsin. Cell Transplant (2012) 0.78

Improvement of collagenase distribution with the ductal preservation for human islet isolation. Islets (2012) 0.78

The editor's roundtable: Hypertension in African Americans and other non-Caucasian ethnic groups. Am J Cardiol (2010) 0.78

The editor's roundtable: lipid management beyond statins-reducing residual cardiovascular risk. Am J Cardiol (2008) 0.78

A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78

Facts and ideas from anywhere. Proc (Bayl Univ Med Cent) (2009) 0.77

The Editor's roundtable: diabetes mellitus and coronary heart disease. Am J Cardiol (2006) 0.77

The editor's roundtable: Acute decompensated heart failure. Am J Cardiol (2007) 0.77

Dobutamine challenge for low-gradient aortic stenosis. Circulation (2002) 0.77

Ectopic transgenic expression of NKX2.2 induces differentiation of adult pancreatic progenitors and mediates islet regeneration. Cell Cycle (2012) 0.77

The editor's roundtable: medical management of atrial fibrillation. Am J Cardiol (2012) 0.76

The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. Am J Cardiol (2012) 0.76

Profound left ventricular remodeling associated with LAMP2 cardiomyopathy. Am J Cardiol (2010) 0.76

The editor's roundtable: high-density lipoprotein cholesterol. Am J Cardiol (2007) 0.76

The first patient clinically diagnosed with hypertrophic cardiomyopathy. Am J Cardiol (2008) 0.76